Do you have a dispute with a business?
Make it public
FOCUS PHARMACEUTICALS LIMITED
DASHWOOD HOUSE, 69 OLD BROAD STREET, LONDON, EC2M 1QSCompany Number: 04522142
Incorporation date: 30-Aug-2002
Status: Active
Entity type: Private Limited Company
SIC codes:
21200 Manufacture of pharmaceutical preparations
46460 Wholesale of pharmaceutical goods
72190 Other research and experimental development on natural sciences and engineering
SUMMARY
This company is 22.2 years old and is currently active. It is controlled by multiple entities. The company has positive equity (net assets) of GBP 4 million which has increased from GBP 1.2 million in the previous year. The latest reported revenue figure is GBP 3.4 million which is down -80% on the previous year. The company has 3 active officers (directors or partners) who are or were officers of 23 other companies, 1 (4.3%) of which have since been dissolved or are proposed for strike off. The company has no public disputes filed on the Business Disputes Register. There are 3 court cases involving the company that we are aware of.FINANCIALS (BETA)
Next accounts due: 30-Sep-2025Accounts Filed: FULL (31-Dec-2023)
P&L Financials:
Year end | Currency | Revenue | Operating profit | Interest Received | Interest Paid | Tax | Net Profit GBP |
---|---|---|---|---|---|---|---|
31-Dec-2019 | GBP | 3,372,967 | 2,739,572 | ||||
31-Dec-2018 | GBP | 21,446,389 | 5,587,220 | -1,060,163 | |||
31-Dec-2017 | GBP | 37,170,564 | 13,342,433 | 1,638 | |||
31-Dec-2016 | GBP | 51,946,249 | 22,427,568 | 6,035 | -4,589,209 | ||
31-Dec-2015 | GBP | 3,053,476 | |||||
31-Dec-2014 | GBP | 38,372,306 | 3,916,869 | 435 | 17,199 | 846,629 | 3,053,476 |
Balance Sheet Financials:
Year end | Currency | Cash | Current Assets | Current Liabilities | Debt | Share Capital | Premium Reserve | Retained Earnings | Net Assets |
---|---|---|---|---|---|---|---|---|---|
31-Dec-2019 | GBP | 520,566 | 6,865,830 | 99 | 355,041 | 3,625,001 | 3,980,141 | ||
31-Dec-2018 | GBP | 5,574,108 | 9,262,858 | 8,283,055 | 99 | 355,041 | 878,697 | 1,233,837 | |
31-Dec-2017 | GBP | 7,567,815 | 17,716,878 | 13,636,942 | 99 | 355,041 | 4,049,285 | 4,404,425 | |
31-Dec-2016 | GBP | 7,093,988 | 21,797,353 | 16,999,559 | 355,140 | 4,757,644 | 5,112,784 | ||
31-Dec-2015 | GBP | 6,845,472 | 24,182,576 | 9,686,009 | 98 | 14,625,680 | 14,625,778 | ||
31-Dec-2014 | GBP | 682,078 | 11,627,480 | 8,278,062 | 98 | 3,496,499 | 3,496,597 |
VALUATION EVENTS (BETA)
Year end | Currency | % Equity | Sum raised | Pre-Money Valuation* | Post-Money Valuation* | Enterprise Value** |
---|---|---|---|---|---|---|
31-Dec-2017 | GBP | -358,627.27% | 0 | 0 | 0 | -7,330,902 |
31-Dec-2016 | GBP | 99.97% | 355,042 | 98 | 355,140 | -6,792,111 |
** Estimated based on average Cash and Debt levels during period
DISPUTES
No disputes filed on www.disputesregister.orgCOMPANY SECRETARY
Status | Name | Appointed on | Resigned on | Occupation | Nationality | All apointments (active/resigned) |
---|---|---|---|---|---|---|
Active | TMF CORPORATE ADMINISTRATION SERVICES LIMITED | 16 Mar 2022 | 02 Nov 2024 | 605 - 1789 | ||
Resigned | Robert SULLY | 01 Oct 2018 | 16 Mar 2022 | 0 - 1 | ||
Resigned | David Richard WILLIAMS | 31 Dec 2016 | 01 Oct 2018 | 0 - 1 | ||
Resigned | Robert James SULLY | 01 Oct 2014 | 31 Dec 2016 | 0 - 1 | ||
Resigned | Richard Paul GRETHE | 01 Dec 2004 | 01 Oct 2014 | Finance Director | British | 0 - 11 |
Resigned | Bronson Raymond MAGINLEY | 01 Oct 2003 | 01 Dec 2004 | British | 1 - 10 | |
Resigned | Linda LEAVER | 28 Oct 2002 | 01 Oct 2003 | British | 4 - 30 |
DIRECTORS
Status | Name | Appointed on | Resigned on | Occupation | Nationality | All appointments (active/resigned) |
Dissolved companies (rate) |
---|---|---|---|---|---|---|---|
Active | Andreas STICKLER | 21 Jan 2022 | Chief Financial Officer | German | 12 - 0 | 1 (8.3%) | |
Active | Andreas STICKLER | 21 Jan 2022 | Chief Financial Officer | German | 1 - 0 | 0 (0.0%) | |
Resigned | Graeme Neville DUNCAN | 30 Nov 2018 | 12 Jan 2022 | Chief Executive Officer | British | 4 - 30 | 1 (2.9%) |
Resigned | Graeme Neville DUNCAN | 30 Nov 2018 | 12 Jan 2022 | Chief Executive Officer | British | 1 - 34 | 1 (2.9%) |
Resigned | Graeme Neville DUNCAN | 31 Dec 2016 | 08 Mar 2018 | President | British | 1 - 34 | 1 (2.9%) |
Resigned | Graeme Neville DUNCAN | 31 Dec 2016 | 08 Mar 2018 | President | British | 4 - 30 | 1 (2.9%) |
Active | Vikram Laxman KAMATH | 31 Dec 2016 | Vice President Finance And Group Controller | British | 15 - 9 | 2 (8.3%) | |
Resigned | Adeel AHMAD | 08 Jan 2016 | 31 Jan 2022 | Chief Financial Officer | Canadian | 0 - 15 | 1 (6.7%) |
Resigned | John BEIGHTON | 01 Oct 2014 | 31 Dec 2016 | Ceo | British | 0 - 7 | 2 (28.6%) |
Resigned | Antonie Pieter VAN TIGGELEN | 01 Oct 2014 | 08 Jan 2016 | Chief Financial Officer | British | 0 - 16 | 4 (25.0%) |
Resigned | Richard Paul GRETHE | 01 Dec 2004 | 01 Oct 2014 | Finance Director | British | 0 - 11 | 6 (54.5%) |
Resigned | Andrew Derrick LEAVER | 28 Oct 2002 | 19 Oct 2007 | Director | British | 7 - 32 | 17 (43.6%) |
Resigned | Mark CRESSWELL | 28 Oct 2002 | 01 Oct 2014 | Managing Director | British | 2 - 8 | 4 (40.0%) |
Resigned | Roland Alexander BROWN | 28 Oct 2002 | 01 Oct 2014 | Marketing Director | British | 0 - 6 | 4 (66.7%) |
Resigned | Bronson Raymond MAGINLEY | 28 Oct 2002 | 01 Oct 2014 | Medical And Regulatory Direct | British | 1 - 10 | 7 (63.6%) |
Resigned | FORM 10 SECRETARIES FD LTD | 30 Aug 2002 | 17 Sep 2002 | 0 - 3977 | 1788 (45.0%) | ||
Resigned | FORM 10 DIRECTORS FD LTD | 30 Aug 2002 | 17 Sep 2002 | 0 - 34786 | 18482 (53.1%) |
Average tenure of active directors: 4.5 years
Average tenure of resigned directors: 4.9 years
Average active director Dissolution Rate: 5.6%
DIRECTOR APPOINTMENTS IN OTHER COMPANIES
SHAREHOLDERS (BETA)
Shareholder name | Share class | Shares at confirmation date | ||||
---|---|---|---|---|---|---|
2017-07-27 | 2015-08-30 | 2014-08-30 | 2013-08-30 | 2012-08-30 | ||
FOCUS PHARMA HOLDINGS LIMITED | ORDINARY | 99 100% | 98 100% | 98 100% | 98 100% | 98 100% |
SHAREHOLDINGS (BETA)
no shareholding data
CONTROLLED COMPANIES / CONTROLLING ENTITIES
Controlling entities above
FOCUS PHARMACEUTICALS LIMITED
no controlled companies
LATE PAYMENTS REPORT
COURT CASES
Date | Title | Reference | Subject |
---|---|---|---|
2016-12-21 | Novartis Ag & Ors v Focus Pharmaceuticals UK Ltd & Ors | [2016] EWCA Civ 1295 | |
2015-06-04 | Novartis Ag & Ors v Focus Pharmaceuticals Ltd & Ors | [2015] EWHC 1553 (Pat) | |
2015-04-27 | Novartis AG & Ors v Focus Pharmaceuticals Ltd & Ors | [2015] EWHC 1068 (Pat) |
PATENTS
No Patents found
COMPETITORS
(Based on Sic code:
21200 Manufacture of pharmaceutical preparations)
Company | Registered Address | Company Number | YE Date | Revenue GBP | Net Profit GBP | Other SIC codes |
---|---|---|---|---|---|---|
GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) TRADING LIMITED | BUILDING 5, FIRST FLOOR, THE HEIGHTS, WEYBRIDGE, SURREY, ENGLAND, KT13 0NY | 09237643 | 2017-12-31 | 907,175,000 | 25,390,000 | |
GLAXO OPERATIONS UK LIMITED | 79 NEW OXFORD STREET, LONDON, UNITED KINGDOM, WC1A 1DG | 00711851 | 2017-12-31 | 751,809,000 | 31,941,000 | |
JANSSEN-CILAG LIMITED | 50-100 HOLMERS FARM WAY, HIGH WYCOMBE, BUCKINGHAMSHIRE, HP12 4EG | 01027904 | 2017-12-31 | 552,543,000 | 35,316,000 | |
TEVA UK LIMITED | RIDINGS POINT, WHISTLER DRIVE, CASTLEFORD, ENGLAND, ENGLAND, WF10 5HX | 00302461 | 2017-12-31 | 522,216,000 | 12,568,000 | |
ACCORD HEALTHCARE LIMITED | SAGE HOUSE, 319 PINNER ROAD, NORTH HARROW, MIDDLESEX, HA1 4HF | 04596349 | 2018-03-31 | 466,881,000 | 8,409,000 |
46460-Wholesale of pharmaceutical goods |
CLINIGEN GROUP PLC | PITCAIRN HOUSE CROWN SQUARE, CENTRUM 100, BURTON ON TRENT, STAFFORDSHIRE, DE14 2WW | 06771928 | 2018-06-30 | 381,200,000 | 27,400,000 |
46460-Wholesale of pharmaceutical goods |
NAPP PHARMACEUTICAL HOLDINGS LIMITED | UNIT 196 CAMBRIDGE SCIENCE PARK, MILTON ROAD, CAMBRIDGE, ENGLAND, CB4 0AB | 03486244 | 2017-12-31 | 289,665,000 | 49,250,000 |
46460-Wholesale of pharmaceutical goods |
ACCORD-UK LTD | WHIDDON VALLEY, BARNSTAPLE, DEVON, EX32 8NS | 00079585 | 2018-03-31 | 278,145,000 | 48,706,000 | |
NORBROOK LABORATORIES LIMITED | STATION WORKS, CAMLOUGH ROAD, NEWRY, CO. DOWN, NORTHERN IRELAND, BT35 6JP | NI007665 | 2018-08-03 | 228,695,000 | 34,314,000 | |
NORTON HEALTHCARE LIMITED | RIDINGS POINT, WHISTLER DRIVE, CASTLEFORD, ENGLAND, ENGLAND, WF10 5HX | 00947980 | 2017-12-31 | 178,230,000 | 83,361,000 | |
QUALASEPT LIMITED | 3 CORSHAM SCIENCE PARK, PARK LANE, CORSHAM, WILTSHIRE, UNITED KINGDOM, SN13 9FU | 05548345 | 2018-04-30 | 166,298,470 | 10,410,672 | |
FRESENIUS KABI LIMITED | CESTRIAN COURT, EASTGATE WAY MANOR PARK, RUNCORN, CHESHIRE, WA7 1NT | 02182135 | 2017-12-31 | 121,048,000 | 3,638,000 | |
OMEGA PHARMA LIMITED | WRAFTON, WRAFTON, BRAUNTON, DEVON, ENGLAND, EX33 2DL | 00922235 | 2017-12-31 | 110,053,000 | 8,501,000 |
46460-Wholesale of pharmaceutical goods |
BARD PHARMACEUTICALS LIMITED | UNIT 191, CAMBRIDGE SCIENCE PARK, MILTON ROAD, CAMBRIDGE, ENGLAND, CB4 0GW | 00987562 | 2017-12-31 | 94,324,000 | 24,235,000 | |
FISONS LIMITED | 410 THAMES VALLEY PARK DRIVE, READING, BERKSHIRE, ENGLAND, RG6 1PT | 00044687 | 2016-12-31 | 89,026,000 | -23,024,000 | |
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED | FUJIFILM DIOSYNTH BIOTECHNOLOGIES, BELASIS AVENUE, BILLINGHAM, TS23 1LH | 05803359 | 2018-03-31 | 81,400,000 | 13,500,000 |
72110-Research and experimental development on biotechnology |
QUANTUM PHARMACEUTICAL LIMITED | QUANTUM HOUSE, HOBSON INDUSTRIAL ESTATE, BURNOPFIELD, CO DURHAM, NE16 6EA | 05240304 | 2018-06-30 | 76,092,000 | -8,345,000 | |
ALMAC PHARMA SERVICES LIMITED | ALMAC HOUSE, 20 SEAGOE INDUSTRIAL ESTATE, CRAIGAVON, BT63 5QD | NI045055 | 2017-09-30 | 69,660,684 | 4,207,021 | |
MORNINGSIDE PHARMACEUTICALS LIMITED | NENE HOUSE, 4 RUSHMILLS, NORTHAMPTON, ENGLAND, NN4 7YB | 02672877 | 2017-12-31 | 62,737,482 | 6,004,935 |
32500-Manufacture of medical and dental instruments and supplies 46460-Wholesale of pharmaceutical goods |
CALEA UK LIMITED | CESTRIAN COURT, EASTGATE WAY MANOR PARK, RUNCORN, CHESHIRE, WA7 1NT | 02506615 | 2017-12-31 | 62,638,000 | 7,746,000 | |
CATALENT CTS (EDINBURGH) LIMITED | . FRANKLAND ROAD, BLAGROVE, SWINDON, WILTSHIRE, ENGLAND, SN5 8YG | 05277708 | 2018-06-30 | 54,067,315 | 16,583,236 | |
DERMAL LABORATORIES LIMITED | HASLERS, OLD STATION ROAD, LOUGHTON, ESSEX, IG10 4PL | 01594795 | 2017-05-31 | 43,052,720 | 0 | |
DERMAL LABORATORIES LIMITED | HASLERS, OLD STATION ROAD, LOUGHTON, ESSEX, IG10 4PL | 01594795 | 2018-05-31 | 41,451,144 | 2,331,327 | |
DR REDDY'S LABORATORIES (UK) LIMITED | 410 CAMBRIDGE SCIENCE PARK, MILTON ROAD, CAMBRIDGE, ENGLAND, CB4 0PE | 01729064 | 2018-03-31 | 40,429,896 | 0 | |
NAPP PHARMACEUTICAL GROUP LIMITED | UNIT 196 CAMBRIDGE SCIENCE PARK, MILTON ROAD, CAMBRIDGE, ENGLAND, CB4 0AB | 00884285 | 2017-12-31 | 38,211,000 | 17,231,000 |
46460-Wholesale of pharmaceutical goods |
FOCUS PHARMACEUTICALS LIMITED | DASHWOOD HOUSE, 69 OLD BROAD STREET, LONDON, UNITED KINGDOM, EC2M 1QS | 04522142 | 2017-12-31 | 37,170,564 | 10,869,254 |
46460-Wholesale of pharmaceutical goods 72190-Other research and experimental development on natural sciences and engineering |
NICOBRAND LIMITED | 189 CASTLEROE ROAD, COLERAINE, COUNTY LONDONDERRY, NORTHERN IRELAND, NORTHERN IRELAND, BT51 3RP | NI033276 | 2017-12-31 | 11,981,230 | 0 | |
AURALIS LIMITED | 1 KINGDOM STREET, LONDON, ENGLAND, W2 6BD | 05335695 | 2017-12-31 | 1,473,000 | 1,251,000 | |
EMERGENCYPHARM LTD. | 69 ROUNDHILL AVENUE, BINGLEY, ENGLAND, BD16 1PQ | 09263308 | 2018-10-31 | 47,990 | 0 | |
AFZAL PHARMA LTD | 156 NORMAN PLACE ROAD, COVENTRY, ENGLAND, CV6 2BU | 09090499 | 2018-06-30 | 30,127 | 0 | |
ARCADIA PHARMA LIMITED | UNIT 3 FELINFACH, FFORESTFACH, SWANSEA, SA5 4HP | 08497840 | 2018-12-31 | 0 | 0 | |
BESCOT HEALTHCARE UK LIMITED | 272 BATH STREET, GLASGOW, G2 4JR | SC474960 | 2019-04-30 | 0 | 0 | |
HYPERION CATALYSIS EU LIMITED | 4385, 06729299 - COMPANIES HOUSE DEFAULT ADDRESS, CARDIFF, CF14 8LH | 06729299 | 2018-03-31 | 0 | 0 |
32990-Other manufacturing not elsewhere classified 72190-Other research and experimental development on natural sciences and engineering |
FOCUS PHARMA HOLDINGS LIMITED | CAPITAL HOUSE, 85 KING WILLIAM STREET, LONDON, EC4N 7BL | 06317129 | 0000-00-00 | 0 | 0 |
46460-Wholesale of pharmaceutical goods 72190-Other research and experimental development on natural sciences and engineering |
QUALASEPT HOLDINGS LIMITED | 3 CORSHAM SCIENCE PARK, PARK LANE, CORSHAM, WILTSHIRE, UNITED KINGDOM, SN13 9FU | 10135621 | 0000-00-00 | 0 | 0 | |
QUANTUM PHARMA 2014 LIMITED | 25 BEDFORD SQUARE, BLOOMSBURY, LONDON, UNITED KINGDOM, WC1B 3HH | 09269809 | 0000-00-00 | 0 | 0 |
70100-Activities of head offices |
QUANTUM PHARMA HOLDINGS LIMITED | 25 BEDFORD SQUARE, BLOOMSBURY, LONDON, UNITED KINGDOM, WC1B 3HH | 09269818 | 0000-00-00 | 0 | 0 | |
REMEDI MEDICAL HOLDINGS LIMITED | NENE HOUSE, 4 RUSHMILLS, NORTHAMPTON, ENGLAND, NN4 7YB | 08735617 | 0000-00-00 | 0 | 0 |
46460-Wholesale of pharmaceutical goods |
LIQUIDATION RISK (BETA)
This company is Active. Statistically, Active companies have a low probability of being liquidated within a year.
Here are our probability predictions:
Basis | Liquidation within 3 months | Liquidation within 6 months | Liquidation within 12 months | Prediction confidence |
---|---|---|---|---|
FOCUS PHARMACEUTICALS LIMITED | 0.7% | 3.6% | 7.1% | Medium |
Other companies Active in the same sector | Too few competitors | |||
Age | 0.3% | 1.3% | 2.4% | Medium |
Company Type | 0.7% | 3.7% | 7.4% | Medium |
Accounts category | 0.7% | 2.2% | 3.8% | Medium |
Accounting Month | 0.6% | 2.4% | 5.5% | Medium |
Sic code count | 0.8% | 4.4% | 8.7% | Medium |